Related Experiment Videos
Carotid sinus hypersensitivity: evaluation of the vasodepressor component
Insights
Atrioventricular sequential pacing and certain medications do not prevent vasodepressor responses in carotid sinus hypersensitivity (CSH). Vasoconstrictors like ephedrine, however, can significantly attenuate these responses.
Area of Science:
- Cardiology
- Clinical Electrophysiology
- Pharmacology
Background:
- The underlying mechanisms of vasodepressor responses in patients with carotid sinus hypersensitivity (CSH) remain unclear.
- Effective strategies for preventing recurrent hypotension induced by vasodepressor responses in CSH patients are lacking.
Purpose of the Study:
- To evaluate the efficacy of atrioventricular sequential pacing and pharmacological interventions in preventing carotid sinus massage (CSM)-induced vasodepressor responses in CSH patients.
Main Methods:
- Eight patients with CSH underwent carotid sinus massage (CSM) under various conditions: control, atrioventricular sequential pacing (maintaining heart rate at 80 bpm and atrioventricular interval at 150 ms), pharmacologic blockade (atropine, atropine plus propranolol), and administration of vasoconstrictors (norepinephrine, ephedrine).
- Systolic blood pressure changes following CSM were measured and compared across different interventions.
Main Results:
- Atrioventricular sequential pacing did not significantly alter the mean fall in systolic pressure induced by CSM.
- Pharmacological blockade with atropine or combined atropine and propranolol also failed to significantly attenuate the CSM-induced drop in systolic pressure.
- Intravenous norepinephrine and oral ephedrine significantly blunted the CSM-induced decrease in systolic pressure (p < .01 compared to pacing alone).
Conclusions:
- Atrioventricular sequential pacing alone is insufficient to prevent hypotension in CSH patients with significant vasodepressor responses.
- Pharmacological muscarinic blockade or combined adrenergic blockade does not effectively prevent these responses.
- Vasoconstrictors, particularly alpha-adrenergic agonists like ephedrine, show promise in attenuating CSM-induced vasodepressor responses and may help diminish symptoms in CSH patients.
Abstract:
The basis of the vasodepressor response in patients with carotid sinus hypersensitivity (CSH) is unknown, and prevention of recurrent vasodepressor-induced hypotension in these patients has not been possible. In this study we assessed the effectiveness of atrioventricular sequential pacing and pharmacologic interventions in the prevention of carotid sinus massage (CSM)-induced vasodepressor responses in eight patients with CSH. Maintenance of constant heart rate (80 beats/min) and atrioventricular synchrony (atrioventricular interval 150 msec) with sequential pacing did not significantly alter mean CSM-induced fall in systolic pressure (CSM control, -60 +/- 12 mm Hg vs CSM with atrioventricular sequential pacing, -48 +/- 19 mm Hg). Similarly, neither pharmacologic muscarinic blockade nor combined muscarinic and beta-adrenergic blockade significantly attenuated CSM-induced fall in systolic pressure (CSM with atropine, -43 +/- 16 mm Hg; CSM with atropine plus propranolol, -47 +/- 18 mm Hg; both p = NS vs atrioventricular sequential pacing alone). On the other hand, intravenous norepinephrine and oral ephedrine blunted the CSM-induced drop in systolic pressure (CSM with norepinephrine, -19 +/- 12 mm Hg; CSM with ephedrine, -21 +/- 11 mm Hg; both p less than .01 vs atrioventricular sequential pacing alone). Thus, vasodepressor responses were not prevented by control of heart rate, maintenance of atrioventricular synchrony, pharmacologic muscarinic blockade, or combined muscarinic and beta-adrenergic blockade, but were attenuated by drugs believed to be predominantly alpha-adrenergic agonists. Consequently, atrioventricular sequential pacing alone may be inadequate to prevent hypotension in patients with pronounced vasodepressor responses, whereas administration of vasoconstrictors such as ephedrine may diminish symptoms.